Simrat Randhawa is VP at Dianthus Therapeutics, Inc. /DE/ (DNTH). They have made 2 open-market trades across 1 company since 2023, most recently 2026-09-01.
CIK 0001992260
1 open-market purchase totalling $53K since 2023, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DNTH | 4,000 | $289K |
Shares reported on the most recent Form 4, priced at the 2026-09-03 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DNTH | SELL · 10b5-1 | 2026-09-01 | 2026-09-03 | $106.41 | $2.5M | -5.0% | -18.6% | — |
| DNTH | SELL · 10b5-1 | 2026-06-01 | 2026-06-02 | $90.62 | $2.4M | -0.6% | +14.4% | +28.0% |
| DNTH | SELL | 2026-03-12 | 2026-03-13 | $81.48 | $2.8M | +2.3% | +15.7% | -1.7% |
| DNTH | SELL · 10b5-1 | 2025-11-13 | 2025-11-14 | $37.55 | $14.8M | +7.8% | +2.6% | +16.2% |
| DNTH | BUY | 2023-09-21 | 2023-09-25 | $13.20 | $53K | -6.6% | -11.0% | -10.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.